Literature DB >> 22447358

Extreme clinical variability of dilated cardiomyopathy in two siblings with Alström syndrome.

Jamal Mahamid1, Avraham Lorber, Yoseph Horovitz, Stavit A Shalev, Gayle B Collin, Jürgen K Naggert, Jan D Marshall, Ronen Spiegel.   

Abstract

Alström syndrome (ALMS) is a rare autosomal recessive disorder caused by mutations in the ALMS1 gene. We report two brothers, 3 and 4 years of age and diagnosed with ALMS, who initially presented in infancy with severe dilated cardiomyopathy during febrile respiratory infection. The disease course in the two siblings was marked by significant intrafamilial variability. Although cardiomyopathy in the older sibling has mainly resolved thus allowing for the discontinuation of medical therapy, heart function in the younger sibling continues to deteriorate despite maximal drug support with furosemide, carvedilol, captopril, and aldospirone. Genetic analysis revealed homozygous mutations, c.8008C>T (R2670X), in ALMS1 resulting in premature protein truncation. This report further emphasizes the exceptional intrafamilial variability of ALMS, mainly during the natural course of cardiac disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447358      PMCID: PMC3779600          DOI: 10.1007/s00246-012-0296-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  14 in total

1.  The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy.

Authors:  J Bond; K Flintoff; J Higgins; S Scott; C Bennet; J Parsons; J Mannon; H Jafri; Y Rashid; M Barrow; R Trembath; G Woodruff; E Rossa; S Lynch; J Sheilds; R Newbury-Ecob; A Falconer; P Holland; D Cockburn; G Karbani; S Malik; M Ahmed; E Roberts; G Taylor; C G Woods
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

2.  Familial variable expression of dilated cardiomyopathy in Alström syndrome: a report of four sibs.

Authors:  J D Hoffman; Z Jacobson; T L Young; J D Marshall; Paige Kaplan
Journal:  Am J Med Genet A       Date:  2005-05-15       Impact factor: 2.802

3.  Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alstrom syndrome.

Authors:  J A L Minton; K R Owen; C J Ricketts; N Crabtree; G Shaikh; S Ehtisham; J R Porter; C Carey; D Hodge; R Paisey; M Walker; T G Barrett
Journal:  J Clin Endocrinol Metab       Date:  2006-05-23       Impact factor: 5.958

4.  Alström syndrome.

Authors:  Jan D Marshall; Sebastian Beck; Pietro Maffei; Jürgen K Naggert
Journal:  Eur J Hum Genet       Date:  2007-10-17       Impact factor: 4.246

5.  New Alström syndrome phenotypes based on the evaluation of 182 cases.

Authors:  Jan D Marshall; Roderick T Bronson; Gayle B Collin; Anne D Nordstrom; Pietro Maffei; Richard B Paisey; Catherine Carey; Seamus Macdermott; Isabelle Russell-Eggitt; Sarah E Shea; Judy Davis; Sebastian Beck; Gocha Shatirishvili; Cristina Maria Mihai; Maria Hoeltzenbein; Giovanni Battista Pozzan; Ian Hopkinson; Nicola Sicolo; Jürgen K Naggert; Patsy M Nishina
Journal:  Arch Intern Med       Date:  2005-03-28

6.  Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome.

Authors:  Gayle B Collin; Jan D Marshall; Akihiro Ikeda; W Venus So; Isabelle Russell-Eggitt; Pietro Maffei; Sebastian Beck; Cornelius F Boerkoel; Nicola Sicolo; Mitchell Martin; Patsy M Nishina; Jürgen K Naggert
Journal:  Nat Genet       Date:  2002-04-08       Impact factor: 38.330

7.  Cardiac manifestations of Alström syndrome: echocardiographic findings.

Authors:  Amgad N Makaryus; Michael E Zubrow; Jan D Marshall; Linda D Gillam; Judy R Mangion
Journal:  J Am Soc Echocardiogr       Date:  2007-09-06       Impact factor: 5.251

8.  ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis.

Authors:  Elisabetta Zulato; Francesca Favaretto; Caterina Veronese; Stefano Campanaro; Jan D Marshall; Sara Romano; Anna Cabrelle; Gayle B Collin; Barbara Zavan; Anna S Belloni; Enrica Rampazzo; Jürgen K Naggert; Giovanni Abatangelo; Nicola Sicolo; Pietro Maffei; Gabriella Milan; Roberto Vettor
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

9.  Cardiac magnetic resonance imaging in Alström syndrome.

Authors:  Margaret A Loudon; Nicholas G Bellenger; Catherine M Carey; Richard B Paisey
Journal:  Orphanet J Rare Dis       Date:  2009-06-10       Impact factor: 4.123

10.  Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes.

Authors:  Tom Hearn; Cosma Spalluto; Victoria J Phillips; Glenn L Renforth; Nane Copin; Neil A Hanley; David I Wilson
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

View more
  3 in total

Review 1.  Mutation identification and prediction for severe cardiomyopathy in Alström syndrome, and review of the literature for cardiomyopathy.

Authors:  Savas Dedeoglu; Elif Dede; Funda Oztunc; Asuman Gedikbasi; Gozde Yesil; Reyhan Dedeoglu
Journal:  Orphanet J Rare Dis       Date:  2022-09-15       Impact factor: 4.303

2.  New pathogenic variants of ALMS1 gene in two Chinese families with Alström Syndrome.

Authors:  Wan-Yu Cheng; Mei-Jiao Ma; Shi-Qin Yuan; Xiao-Long Qi; Wei-Ning Rong; Xun-Lun Sheng
Journal:  BMC Ophthalmol       Date:  2022-09-26       Impact factor: 2.086

Review 3.  Alström syndrome: current perspectives.

Authors:  María Álvarez-Satta; Sheila Castro-Sánchez; Diana Valverde
Journal:  Appl Clin Genet       Date:  2015-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.